Showing results (91-100 of 148) with videos related to

Sort By:
Pageof 15
Journal of Neurology, Neurosurgery, and Psychiatry|February 15, 2018
Plasma tau is increased in frontotemporal dementiaMartha S Foiani, Ione Oc Woollacott, Carolin Heller, et al.
Dementia and Geriatric Cognitive Disorders|April 29, 2020
Cerebrospinal Fluid YKL-40 and Chitotriosidase Levels in Frontotemporal Dementia Vary by Clinical, Genetic and Pathological SubtypeIone O C Woollacott, Jennifer M Nicholas, Carolin Heller, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 26, 2025
Cerebrospinal Fluid Proenkephalin Predicts Striatal Atrophy Decades before Clinical Motor Diagnosis in Huntington's DiseaseMena Farag, Michael J Murphy, Nicola Z Hobbs, et al.
Brain Communications|May 14, 2023
Predictive blood biomarkers and brain changes associated with age-related cognitive declineTyler S Saunders, Francesca E Pozzolo, Amanda Heslegrave, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 29, 2025
Plasma Biomarkers and Disease Prognosis in Mild Cognitive Impairment with Lewy BodiesPaul C Donaghy, Jahfer Hasoon, Calum A Hamilton, et al.
BMJ Open|May 23, 2023
Investigating the characteristics and correlates of systemic inflammation after traumatic brain injury: the TBI-BraINFLAMM studyLucia M Li, Amanda Heslegrave, Eyal Soreq, et al.
Journal of Alzheimer'S Disease : JAD|March 17, 2020
Cerebrospinal Fluid Biomarkers in Cerebral Amyloid AngiopathyGargi Banerjee, Gareth Ambler, Ashvini Keshavan, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 27, 2025
Novel blood-based proteomic signatures across multiple neurodegenerative diseasesRobert Durcan, Amanda Heslegrave, Peter Swann, et al.
Brain : a Journal of Neurology|July 12, 2023
Peripherin is a biomarker of axonal damage in peripheral nervous system diseaseStephen Keddie, Duncan Smyth, Ryan Y S Keh, et al.
Molecular Psychiatry|March 6, 2021
Evaluation of plasma tau and neurofilament light chain biomarkers in a 12-year clinical cohort of human prion diseasesAndrew G B Thompson, Prodromos Anastasiadis, Ronald Druyeh, et al.
Pageof 15